Prescription drug · ANDA
Triazolam NDC 72789-349
Triazolam .25 mg/1 · Tablet · Oral · PD-Rx Pharmaceuticals, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 72789-349-30 | 72789034930 | 30 TABLET in 1 BOTTLE, PLASTIC (72789-349-30)Marketed from Aug 17, 2023 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Triazolam
- Generic name (nonproprietary)
- triazolam
- Active ingredients
- Triazolam — .25 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- PD-Rx Pharmaceuticals, Inc.NDC labeler code 72789
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 214219
- Marketing start
- Listing expires
- DEA schedule
- CIV
- Other FDA classes
- Benzodiazepines (Chemical structure)
- Identifiers
- Product ID 72789-349_40bb635a-95e9-a7d3-e063-6294a90a6ed5SPL ID 40bb635a-95e9-a7d3-e063-6294a90a6ed5SPL set ID f8ca4773-e201-4cb9-8869-5ee07ba1d0bfRxCUI 198318UNII 1HM943223RUPC 0372789349305
- Pharmacologic class
- Benzodiazepine
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N472789034930followed by a unit qualifier and the quantityPackage 72789-0349-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
Triazolam is indicated for the short-term treatment of insomnia (generally 7 to 10 days) in adults. Triazolam is a benzodiazepine indicated for the short-term treatment of insomnia (generally 7 to 10 days) in adults.
Excerpt only. Read the full label for complete information.
About NDC 72789-349
- What is NDC 72789-349?
- 72789-349 is the product NDC for Triazolam, Triazolam .25 mg/1 tablet, listed with the FDA by PD-Rx Pharmaceuticals, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Triazolam.
- What is the active ingredient?
- Triazolam.
- Who is the labeler?
- PD-Rx Pharmaceuticals, Inc., NDC labeler code 72789. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Triazolam?
- 13 other product NDCs are listed under this name. See all Triazolam NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Triazolam products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Triazolam | Triazolam .25 mg/1 | TabletOral | A-S Medication Solutions | 50090-7787 | 50090-7787-0050090-7787-01 |
| Triazolam | Triazolam .25 mg/1 | TabletOral | Zydus Pharmaceuticals USA Inc. | 70710-1289 | 70710-1289-0170710-1289-0570710-1289-08 |
| Triazolam | Triazolam .125 mg/1 | TabletOral | Zydus Pharmaceuticals USA Inc. | 70710-1521 | 70710-1521-0170710-1521-0570710-1521-08 |
| Triazolam | Triazolam .25 mg/1 | TabletOral | Zydus Lifesciences Limited | 70771-1162 | 70771-1162-0170771-1162-0570771-1162-08 |
| Triazolam | Triazolam .125 mg/1 | TabletOral | Zydus Lifesciences Limited | 70771-1576 | 70771-1576-0170771-1576-0570771-1576-08 |
| Triazolam | Triazolam .25 mg/1 | TabletOral | A-S Medication Solutions | 50090-6471 | 50090-6471-0050090-6471-01 |
| Triazolam | Triazolam .125 mg/1 | TabletOral | Ingenus Pharmaceuticals, LLC | 50742-645 | 50742-0645-01 |
| Triazolam | Triazolam .25 mg/1 | TabletOral | Ingenus Pharmaceuticals, LLC | 50742-646 | 50742-0646-0150742-0646-05 |
| Triazolam | Triazolam .25 mg/1 | TabletOral | Bryant Ranch Prepack | 71335-1876 | 71335-1876-0071335-1876-0171335-1876-02+7 more |
| Triazolam | Triazolam .25 mg/1 | TabletOral | Proficient Rx LP | 82804-275 | 82804-0275-30 |
Other NDCs under ANDA 214219
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Triazolam | Triazolam .25 mg/1 | TabletOral | A-S Medication Solutions | 50090-6471 |
| Triazolam | Triazolam .125 mg/1 | TabletOral | Ingenus Pharmaceuticals, LLC | 50742-645 |
| Triazolam | Triazolam .25 mg/1 | TabletOral | Ingenus Pharmaceuticals, LLC | 50742-646 |
| Triazolam | Triazolam .25 mg/1 | TabletOral | Bryant Ranch Prepack | 71335-1876 |
| Triazolam | Triazolam .25 mg/1 | TabletOral | Proficient Rx LP | 82804-275 |